Stay updated on DTX301 Clinical Trial in Late-Onset OTC Deficiency
Sign up to get notified when there's something new on the DTX301 Clinical Trial in Late-Onset OTC Deficiency page.

Latest updates to the DTX301 Clinical Trial in Late-Onset OTC Deficiency page
- CheckyesterdayChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAn NIH-wide banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” during a transition. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check29 days agoChange DetectedThe displayed site revision updates from v3.7.0 to v3.7.1 while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now presents a 403 Forbidden error, indicating access is blocked. This replaces the previous study-record content with a standard error UI including header and footer.SummaryDifference19%

- Check64 days agoChange DetectedThe page shows revision v3.6.6, replacing v3.6.5. This reflects a minor maintenance update to the page version history and does not indicate substantive changes to study details.SummaryDifference0.1%

- Check71 days agoChange DetectedA new line '2016 ( U.S. NIH Grant/Contract )' was added to the study's identifiers to reflect NIH funding; the update appears within the study's funding/identification details.SummaryDifference0.1%

Stay in the know with updates to DTX301 Clinical Trial in Late-Onset OTC Deficiency
Enter your email address, and we'll notify you when there's something new on the DTX301 Clinical Trial in Late-Onset OTC Deficiency page.